# Alzheimer's Disease Keywords
# One keyword per line
# Lines starting with # are comments and will be ignored

# Core Alzheimer's terms
alzheimer
alzheimers
alzheimer's
dementia
cognitive decline
cognitive impairment
memory loss
neurodegeneration
neurodegenerative

# Clinical trial terms
clinical trial
phase 1
phase 2
phase 3
phase I
phase II
phase III
trial results
study enrollment

# Treatment and drug related
treatment
therapy
therapeutic
drug approval
FDA approval
breakthrough therapy
investigational drug
monoclonal antibody
immunotherapy
neuroprotective

# Specific drugs
lecanemab
donanemab
aducanumab
gantenerumab

# Disease mechanisms
amyloid
beta-amyloid
tau protein
anti-amyloid
amyloid-beta
plaque

# Research and diagnosis
biomarker
early detection
diagnosis
diagnostic test
brain imaging
PET scan
cerebrospinal fluid
blood test

# Disease stages
mild cognitive impairment
MCI
early-stage
prodromal
preclinical

# Outcomes and measurements
cognitive function
disease progression
ADAS-Cog
MMSE

# Organizations
NIH
National Institute on Aging
Alzheimer's Association
